Scientists used a bacterial system called retron to turn DNA into a programmable tool inside living cells, enabling gene regulation and disease detection. The non-genetic DNA platform leverages a ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
Cancer incidence rises sharply with age, yet the biological mechanisms that make older patients more vulnerable to treatment failure remain poorly ...
Schematic of the T7-ORACLE system. The genome is maintained by the non-mutagenic host replisome (gray), while an orthogonal T7 replisome (red) maintains only a dedicated plasmid (OR) at 100,000-fold ...
Morning Overview on MSN
DNA-based system targets cancer cells and releases drugs at tumors
Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a cell’s surface, decides whether the cell is cancerous, and then floods it ...
A new platform enables fast, scalable protein evolution - opening the door to new therapies and diagnostics, and to predicting resistance mutations across many disease areas. (Nanowerk News) In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results